The Pyrazolo[3,4-<i>d</i>]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma

Si306, a pyrazolo[3,4-<i>d</i>]pyrimidine derivative recently identified as promising anticancer agent, has shown favorable in vitro and in vivo activity profile against neuroblastoma (NB) models by acting as a competitive inhibitor of c-Src tyrosine kinase. Nevertheless, Si306 antitumor activity is...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Enrico Rango, Fabio Pastorino, Chiara Brignole, Arianna Mancini, Federica Poggialini, Salvatore Di Maria, Claudio Zamperini, Giulia Iovenitti, Anna Lucia Fallacara, Samantha Sabetta, Letizia Clementi, Massimo Valoti, Silvia Schenone, Adriano Angelucci, Mirco Ponzoni, Elena Dreassi, Maurizio Botta
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2022-03-01
Serie:	Biomedicines
Ämnen:	neuroblastoma c-Src inhibitor liposomes anti-GD2 monoclonal antibody immunoliposomes
Länkar:	https://www.mdpi.com/2227-9059/10/3/659
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!